DaVita (LTS:0I7E) Marketable Securities : $21 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is DaVita Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. DaVita's Marketable Securities for the quarter that ended in Sep. 2024 was $21 Mil.

DaVita's annual Marketable Securities increased from Dec. 2021 ($22 Mil) to Dec. 2022 ($78 Mil) but then declined from Dec. 2022 ($78 Mil) to Dec. 2023 ($12 Mil).

DaVita Marketable Securities Historical Data

The historical data trend for DaVita's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Marketable Securities Chart

DaVita Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

11.57

20.10

22.31

77.69

11.61

DaVita Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial															11.71	11.61	10.61	20.69	21.00

DaVita Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

DaVita (LTS:0I7E) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

DaVita Marketable Securities Related Terms

Thank you for viewing the detailed overview of DaVita's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

DaVita Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (LTS:0I7E) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

DVA:USA TRL:Germany TRL:Germany DVAI34:Brazil

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

DaVita Headlines

No Headlines